On April 23, we suggested investors take a bullish posture on NVO, the maker of Ozempic (a popular diabetes therapy) and Wegovy (the popular weight loss drug). This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post Apple Inc: AAPLNext PostDollar General: DG You Might Also Like King Dollar or Court Jester (UUP) June 12, 2019 Intercontinental Exchange: ICE August 30, 2022 XOM: Exxon Mobile (Updated) January 12, 2021
You Might Also Like King Dollar or Court Jester (UUP) June 12, 2019 Intercontinental Exchange: ICE August 30, 2022 XOM: Exxon Mobile (Updated) January 12, 2021
